Drug Shortage Report for FRAXIPARINE

Last updated on 2022-03-02 History
Report ID 149194
Drug Identification Number 02236913
Brand name FRAXIPARINE
Common or Proper name nadroparin calcium injection (0.3 mL)
Company Name ASPEN PHARMACARE CANADA INC.
Market Status DORMANT
Active Ingredient(s) NADROPARIN CALCIUM
Strength(s) 9500UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 10 PF Syringe
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-03-01
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-03-02
Company comments GR96389CA1
Health Canada comments
Tier 3 Status No
Contact Address UNIT 8, 1155 NORTH SERVICE ROAD WEST
OAKVILLE, ONTARIO
CANADA L6M 3E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-03-02 English Compare
v4 2021-12-22 French Compare
v3 2021-12-22 English Compare
v2 2021-11-12 French Compare
v1 2021-11-12 English Compare

Showing 1 to 5 of 5